DK0966277T3 - Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdom - Google Patents
Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdomInfo
- Publication number
- DK0966277T3 DK0966277T3 DK98908904T DK98908904T DK0966277T3 DK 0966277 T3 DK0966277 T3 DK 0966277T3 DK 98908904 T DK98908904 T DK 98908904T DK 98908904 T DK98908904 T DK 98908904T DK 0966277 T3 DK0966277 T3 DK 0966277T3
- Authority
- DK
- Denmark
- Prior art keywords
- disease
- nsaids
- prevent alzheimer
- alzheimer
- nsaid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/814,490 US6160018A (en) | 1995-03-13 | 1997-03-10 | Prophylactic composition and method for alzheimer's Disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0966277T3 true DK0966277T3 (da) | 2006-03-27 |
Family
ID=25215202
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98908904T DK0966277T3 (da) | 1997-03-10 | 1998-03-04 | Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdom |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP1642575B1 (da) |
| JP (1) | JP2001514655A (da) |
| AT (2) | ATE311865T1 (da) |
| AU (1) | AU6682298A (da) |
| CA (1) | CA2283255C (da) |
| DE (2) | DE69841267D1 (da) |
| DK (1) | DK0966277T3 (da) |
| ES (1) | ES2253810T3 (da) |
| WO (1) | WO1998040061A1 (da) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2163986B1 (es) * | 1999-07-13 | 2003-02-16 | Menarini Lab | Acidos-alfa-arilpropionicos y arilaceticos como inhibidores de la ciclooxigenasa-ii. |
| WO2001078721A1 (en) * | 2000-04-13 | 2001-10-25 | Mayo Foundation For Medical Education And Research | Aβ42 LOWERING AGENTS |
| AU2003272539A1 (en) * | 2002-09-17 | 2004-04-08 | New York University | Methods of treating age associated memory impairment (aami), mild cognitive impairment (mci), and dementias with cell cycle inhibitors |
| JP2006510603A (ja) * | 2002-10-07 | 2006-03-30 | アンコール ファーマスーティカルズ インコーポレイテッド | Ｒ−非ステロイド性抗炎症薬エステル及びそれらの使用 |
| US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| CA2532207A1 (en) * | 2003-07-11 | 2005-07-21 | Myriad Genetics, Inc. | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease |
| US8110681B2 (en) * | 2006-03-17 | 2012-02-07 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Compounds for the treatment of spinal muscular atrophy and other uses |
| US20090221703A1 (en) | 2006-07-09 | 2009-09-03 | Chongxi Yu | High penetration composition and uses thereof |
| US20090238763A1 (en) | 2006-07-09 | 2009-09-24 | Chongxi Yu | High penetration compositions and uses thereof |
| US20100173960A1 (en) * | 2006-09-21 | 2010-07-08 | Antonio Cruz | The Combination of a Cyclohexanehexol and a NSAID for the Treatment of Neurodegenerative Diseases |
| KR20210103586A (ko) | 2007-06-04 | 2021-08-23 | 테크필즈 인크 | 매우 높은 피부 및 막 침투율을 가지는 비스테로이드성 소염제(ｎｓａｉａ) 약물전구체 및 이들의 새로운 의약적 용도 |
| MX379054B (es) | 2008-12-04 | 2025-03-11 | Chongxi Yu | Composiciones de alta penetracion y sus aplicaciones. |
| RU2683934C2 (ru) | 2012-01-18 | 2019-04-03 | Текфилдз Фарма Ко., Лтд. | Композиции, содержащие пролекарства с высокой проницаемостью, и фармацевтическая композиция для лечения состояний легких |
| EP3022560B1 (en) | 2013-07-11 | 2020-09-02 | University of North Texas Health Science Center at Fort Worth | Blood-based screen for detecting neurological diseases in primary care settings |
| CA3089881C (en) | 2013-11-26 | 2024-04-02 | University Of North Texas Health Science Center At Fort Worth | Personalized medicine approach for treating cognitive loss |
| CA3088512C (en) | 2018-01-18 | 2023-09-19 | University Of North Texas Health Science Center At Fort Worth | Companion diagnostic for nsaids and donepezil for treating specific subpopulations of patients suffering from alzheimer's disease |
| US20230038360A1 (en) * | 2019-12-20 | 2023-02-09 | Basf Se | Composition for the treatment of amyloid-beta associated diseases |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4028906A1 (de) * | 1990-09-12 | 1992-03-19 | Paz Arzneimittelentwicklung | Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen |
| US5192753A (en) * | 1991-04-23 | 1993-03-09 | Mcgeer Patrick L | Anti-rheumatoid arthritic drugs in the treatment of dementia |
| FR2687915B1 (fr) * | 1992-02-28 | 1995-05-05 | Rhone Poulenc Rorer Sa | Composition pharmaceutique utilisable comme analgesique contenant l'acide (benzoyl-3 phenyl)-2 propionique-(r). |
| US5331000A (en) * | 1992-03-09 | 1994-07-19 | Sepracor Inc. | Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen |
| US5382591A (en) * | 1992-12-17 | 1995-01-17 | Sepracor Inc. | Antipyretic and analgesic methods using optically pure R-ketorolac |
| US5955504A (en) * | 1995-03-13 | 1999-09-21 | Loma Linda University Medical Center | Colorectal chemoprotective composition and method of preventing colorectal cancer |
| US6160018A (en) * | 1995-03-13 | 2000-12-12 | Loma Linda University Medical Center | Prophylactic composition and method for alzheimer's Disease |
| AU3641597A (en) * | 1996-06-21 | 1998-01-07 | Advanced Research And Technology Institute, Inc. | Methods and compositions comprising r-ibuprofen |
-
1998
- 1998-03-04 JP JP53961998A patent/JP2001514655A/ja active Pending
- 1998-03-04 WO PCT/US1998/004176 patent/WO1998040061A1/en not_active Ceased
- 1998-03-04 DE DE69841267T patent/DE69841267D1/de not_active Expired - Lifetime
- 1998-03-04 DK DK98908904T patent/DK0966277T3/da active
- 1998-03-04 AT AT98908904T patent/ATE311865T1/de active
- 1998-03-04 ES ES98908904T patent/ES2253810T3/es not_active Expired - Lifetime
- 1998-03-04 AU AU66822/98A patent/AU6682298A/en not_active Abandoned
- 1998-03-04 EP EP05026505A patent/EP1642575B1/en not_active Expired - Lifetime
- 1998-03-04 DE DE69832695T patent/DE69832695T2/de not_active Expired - Lifetime
- 1998-03-04 CA CA002283255A patent/CA2283255C/en not_active Expired - Fee Related
- 1998-03-04 AT AT05026505T patent/ATE446748T1/de not_active IP Right Cessation
- 1998-03-04 EP EP98908904A patent/EP0966277B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69832695T2 (de) | 2006-09-14 |
| AU6682298A (en) | 1998-09-29 |
| EP0966277A1 (en) | 1999-12-29 |
| ATE311865T1 (de) | 2005-12-15 |
| DE69832695D1 (de) | 2006-01-12 |
| EP1642575A1 (en) | 2006-04-05 |
| EP0966277B1 (en) | 2005-12-07 |
| EP1642575B1 (en) | 2009-10-28 |
| DE69841267D1 (de) | 2009-12-10 |
| WO1998040061A1 (en) | 1998-09-17 |
| CA2283255C (en) | 2007-01-02 |
| ATE446748T1 (de) | 2009-11-15 |
| JP2001514655A (ja) | 2001-09-11 |
| ES2253810T3 (es) | 2006-06-01 |
| CA2283255A1 (en) | 1998-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0966277T3 (da) | Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdom | |
| NZ334124A (en) | Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
| ID24487A (id) | Senyawa-senyawa benzosikloheptatiofen | |
| FI912621A7 (fi) | Farmakologisesti aktiivisia keskushermostoon vaikuttavia yhdisteitä | |
| DK0979079T3 (da) | Anvendelse af tetrahydropyridinderivater til fremstilling af lægemidler til behandling af sygdomme, der medförer en demyelinisering | |
| IT1302243B1 (it) | Sintesi dell'1,1,1,3,3-pentafluoropropano. | |
| DE69808440D1 (de) | Verwendung von (+)mefloquine zur behandlung von malaria | |
| DE60128100D1 (de) | Analgetisches arzneimittel | |
| ES2177024T3 (es) | Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer. | |
| DZ1576A1 (fr) | Compostions therapeutiques à base de dérives de 1,2-dithiole-3-thione. | |
| DK0424156T3 (da) | Behandling af hepatobiliær sygdom med 15-ketoprostaglandinforbindelser | |
| FI912622A7 (fi) | Farmakologisesti aktiivisia keskushermostoon vaikuttavia yhdisteitä | |
| WO2000010554A3 (en) | Methods and compositions employing optically pure s(+) vigabatrin | |
| DK0896822T3 (da) | 4-aminopyrrol (3,2-d) pyrimidiner som neuropeptide Y receptorantagonister | |
| WO2002099422A3 (en) | Individualization of therapy with alzheimer's disease agents | |
| DK0454429T3 (da) | Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme | |
| IT1296613B1 (it) | Farmaco per la cura dell'ircismo contenente un adrenocorticosteroide. | |
| EE200200215A (et) | 2-amino-3,4-dihüdrokinasoliinide kasutamine ravimi valmistamiseks, mis on ette nähtud isheemilistest seisunditest tingitud haiguste raviks või ennetamiseks | |
| SE9501773D0 (sv) | New use | |
| MXPA02002486A (es) | Uso de dexrazoxano para tratar la psoriasis. | |
| FR2680953B1 (fr) | Semelle deodorante, antibacteries, hydrothermique jetable. | |
| SE9304236D0 (sv) | New use | |
| NO970190D0 (no) | Preparat til behandling av Parkinsons sykdom | |
| FI961410A7 (fi) | Farmakologisesti aktiivisia keskushermostoon vaikuttavia yhdisteitä | |
| WO2000051684A3 (en) | Regulators of coenzyme-a-independent transacylase as psychotropic drugs |